Global Life Sciences IT Spending Forecast through 2014 (Interactive Model)

Introduction

tbdAs pharmaceutical and biotechnology companies increasingly turn to IT to reduce costs and time-to-market of a drug, it is important for technology vendors to understand where growth opportunities exist in the global life sciences market. This model will provide a forecast and analysis of IT spending in the pharma/biotech industries through 2014.

Scope

Highlights

Reasons to Purchase

• Understand the opportunity size for technology spending in the global life sciences market
• Identify potential areas for spending growth amongst pharmaceutical and biotechnology companies
• Segment the life sciences industry by spending opportunities